Aimmune Therapeutics Inc (Aimmune), a subsidiary of Societe Des Produits Nestle SA, is a clinical-stage biopharmaceutical company. It develops proprietary product candidates for the treatment of peanut, gastrointestinal and metabolic-related diseases. The company's product pipeline includes AR101- Peanut Allergy Powder-dnfp (PALFORZIA), used to treat peanut allergy. Its gastrointestinal pipeline products portfolio comprises CDX-7108 for exocrine pancreatic insufficiency, SER-287 and SER-30 ulcerative colitis, and PheFlo (CDX-6114) for phenylketonuria. Aimmune also discovers, develops and commercializes therapies related to food allergy. The company conducts research and development in collaboration with leading biotechnology companies. It operates in the US, Ireland, Germany and the UK. Aimmune is headquartered in New Jersey, the US.
Aimmune Therapeutics Inc premium industry data and analytics
Products and Services
Products |
---|
Pipeline |
AR101: Peanut Allergy Powder-DNFP (PALFORZIA) |
AR601: Multi-Nut Allergy |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Aimmune Therapeutics Inc | Abgent | Eidos Therapeutics Inc | Immunomic Therapeutics Inc | Ridgeback Biotherapeutics LP |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Bridgewater | San Diego | San Francisco | Rockville | Miami |
State/Province | New Jersey | California | California | Maryland | Florida |
No. of Employees | - | - | 45 | - | - |
Entity Type | Private | Private | Private | Private | Private |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Andrew Oxtoby | Chief Executive Officer; President | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward